Does VALSARTAN Cause Basal cell carcinoma? 106 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 106 reports of Basal cell carcinoma have been filed in association with VALSARTAN (valsartan). This represents 0.5% of all adverse event reports for VALSARTAN.
106
Reports of Basal cell carcinoma with VALSARTAN
0.5%
of all VALSARTAN reports
25
Deaths
50
Hospitalizations
How Dangerous Is Basal cell carcinoma From VALSARTAN?
Of the 106 reports, 25 (23.6%) resulted in death, 50 (47.2%) required hospitalization, and 25 (23.6%) were considered life-threatening.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALSARTAN. However, 106 reports have been filed with the FAERS database.
What Other Side Effects Does VALSARTAN Cause?
Drug ineffective (1,845)
Blood pressure increased (1,682)
Dizziness (1,527)
Headache (1,361)
Hypertension (1,341)
Acute kidney injury (1,301)
Dyspnoea (1,239)
Fatigue (1,156)
Malaise (1,139)
Hypotension (1,032)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which VALSARTAN Alternatives Have Lower Basal cell carcinoma Risk?
VALSARTAN vs VALTREX
VALSARTAN vs VAMOROLONE
VALSARTAN vs VANCOMYCIN
VALSARTAN vs VANDETANIB
VALSARTAN vs VARDENAFIL